Ningbo David Medical Device Co., Ltd. (300314.SZ)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.64B
EV5.64B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
33.1
32.0
38.6
44.3
43.7
51.9
66.9
69.1
73.7
82.5
Revenue % Chg.
4.6%
-3.4%
20.7%
14.7%
-1.2%
18.7%
29.0%
3.2%
6.7%
18.7%
Cost of Revenue
15.4
15.1
18.0
21.5
21.6
24.0
27.7
26.5
30.5
34.4
Gross Profit
17.7
16.9
20.5
22.8
22.2
27.9
39.2
42.5
43.2
48.1
Gross Profit Margin
53.5%
52.8%
53.2%
51.4%
50.7%
53.8%
58.6%
61.6%
58.6%
58.3%
R&D Expenses
2.0
2.0
2.1
2.6
4.1
5.9
5.9
7.2
6.7
6.8
Selling, General, & Admin Expenses
4.6
5.1
6.0
7.4
9.0
10.9
14.3
19.7
18.2
19.1
Other Expenses
3.2
3.1
3.3
3.7
2.6
3.1
4.3
4.9
4.1
4.4
Operating Income
7.9
6.6
9.1
9.0
6.5
10.5
21.5
12.7
16.3
22.7
Operating Income Margin
24.0%
20.6%
23.5%
20.4%
14.9%
20.2%
32.2%
18.4%
22.1%
27.6%
Total Other Income/Expenses Net
1.4
1.3
1.7
-0.5
-0.7
-0.3
-0.2
-0.0
-0.0
0.0
Income Before Tax
9.3
7.9
10.8
8.6
5.8
10.2
21.4
12.7
16.3
22.7
Income Before Tax Margin
28.2%
24.6%
27.9%
19.4%
13.3%
19.6%
31.9%
18.4%
22.1%
27.6%
Income Tax Expense
1.5
1.3
1.7
1.7
1.6
1.1
1.5
1.0
2.1
2.6
Net Income
7.8
6.5
9.1
6.9
4.2
9.0
19.8
11.7
14.2
20.1
Net Income Margin
23.6%
20.5%
23.5%
15.5%
9.6%
17.4%
29.6%
16.9%
19.3%
24.4%
Weighted Avg. Shares Out
283.8
280.8
282.6
294.0
288.1
282.1
289.8
286.5
287.0
—
EPS
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
—
EPS % Chg.
-15.0%
-15.3%
37.5%
-27.3%
-37.5%
120.0%
113.6%
-40.4%
21.4%
—
Weighted Avg. Shares Out Dil
283.8
280.8
282.6
294.0
288.1
282.1
289.8
286.5
287.0
—
EPS Diluted
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
—
Interest Income
1.4
1.1
0.2
0.2
0.2
0.6
0.4
0.4
0.8
0.4
Interest Expense
1.3
1.2
0.3
—
—
-1.6
-0.0
0.0
0.1
0.1
EBIT
9.4
7.8
10.7
8.8
6.0
12.3
21.8
13.1
17.0
23.1
EBIT Margin
28.3%
24.4%
27.6%
19.8%
13.7%
23.8%
32.5%
19.0%
23.1%
28.0%
Depreciation & Amortization
1.4
1.4
1.7
2.5
3.0
1.2
3.0
3.8
3.9
0.3
EBITDA
10.7
9.2
12.4
11.3
9.0
13.5
24.7
17.0
20.9
23.4
EBITDA Margin
32.5%
28.7%
32.1%
25.5%
20.6%
26.0%
36.9%
24.6%
28.4%
28.4%